Allergic contact dermatitis to chromates has been recognized for many years. Recently crossreactions between hexavalent and trivalent chromium salts have been reported. Several questions remain unanswered. Why is hexavalent chromium more immunologically active? Do percutaneous absorption rates account for all the clinical differences observed? What is the importance of the carrier-protein? Recently, we have sought these answers employing guinea pigs as an experimental model.
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As a preliminary step in the study of reactions of guinea pigs to chromium-protein complexes, attempts were made to sensitize the animals to potassium dichromate and chromic chloride. When the techniques of Hunziker (1) and Van Neer (2) were employed, the results were inconsistent and disappointing. The rate of successful sensitization, as determined by de- layed papular reactions to intradermal tests, never exceeded 20%. Therefore, we reevaluated and modified the procedures, until after several trials our techniques gave consistently successful results. The details are presented along with other pertinent information regarding crossreactivity of several chromium salts. rnocxouan Albino guinea pigs weighing 300 and 500 Gm. were sensitized to hexavalent chromium (K,Cr,O,) by three subcutaneous injections in the nape one week apart. The following emulsion was injected: 0.5 cc Freund's complete adjuvant (Difco) with 0.5 cc of 3.4 X 10 M of K,Cr207 . t Post-doctoral trainee-PH5 TI-AM 05261. t A concentration 3.4 X 10 M is equivalent to 0.1% solution (W/V) of K,Cr,O7, each 0.5 cc containing 0.5 mg of the salt; so that each guinea pig receives a total of 1.5 mg of K,Cr,07. This represents the reference concentration for serial dilu- Having established delayed hypersensitivity to hexavalent and trivalent chromium compounds, several sets of experiments relative to cross-reactions were performed. Animals sensitized with K,Cr,O7 or CrC1, were tested with both compounds and a number of additional trivalent salts. Moreover, they were also exposed to conjugates of chromium linked with plasma proteins and skin extract proteins (modification of the technique of Salvin and Smith) (4, 5) .
REsULTs
Initial sensitizotion: After the above sensitization to K,Cr2O,, twenty-six of twenty-seven previously unexposed guinea pigs developed positive skin tests to K2Cr5O, . In all cases the 48 hour intradermal skin test result was an indurated erythematous papulc of at least 10 mm (+1 response). In twenty-three of the animals the response measured over 15 mm (+2); in twelve the response was greater than 20 mm (+3); and in two, central necrosis developed in the reaction (+4).
When CrCl, was used for sensitization, ten of tions. We are in complete agreement with Epstein (3), who has stressed the importance of expressing concentrations in molarity rather than weight! volume as this usage allows for immediate, accurate comparison of the actual quantity of the Cr None developed (+3) or (+4) reactions.
Cross-reactions: Of the twenty-six guinea pigs sensitized to K,Cr207 (Cr1), all reacted to CrC13 (Cr111) (see Table I ). In most cases the reaction to Cry5 was of greater magnitude, but in seven animals the degree of reactivity was the same and in one there was a greater reaction to Cr111 than to Cr1 . The difference in reactivity to Cr1 and Cr115 is significant at P= 0.005, employing the Wilcoxon matched pairs, signed-rank test (6) . Of the ten guinea pigs sensitized to CrC11, eight also reacted to K,Cr2O7 (see Table II ). In five cases the degree of reactivity was identical. In one case there was a greater reaction to Cr1 than Cr111 . The differences in reactivity are not statistically significant.
Reactions to other trivalent salts: Studies of a similar nature were conducted with four other solutions of trivalent chromium salts. The highest concentrations which were not irritating to control animals were determined by serial dilution and subsequently used for skin testing. They are as follows: Chromic acetate (2.5 X 10' M), chromic nitrate (9.6 x 10), chromie oxalate (2.5 >< 10-4M), chromic sulfate (2.4 X 10 M). Three guinea pigs highly sensitive to K2Cr2O7 had significant cross-reactions to the acetate, nitrate, chloride, and sulfate, but not the oxalate salt (see Table III ). Three animals sensitized to CrCl3 showed weaker cross-reactions to the same compounds (see Table IV ).
Attempts to sensitize guinea pigs with the Reoctions to chromium-protein conjugates: It was not possible to sensitize guinea pigs to conjugates of K2Cr2O7 with guinea pig serum albumin, globulin, or guinea pig skin extract, by using Freund's adjuvant and the above described schedule. The experiments with CrCl,, conjugated to the same proteins also failed to evoke sensitivity to either the conjugate or the salt by itself. Similarly, when animals which were sensitized to either K2Cr2O, or CrCl3 with Freund's complete adjuvant, as described above, were tested with chromium-protein conjugates (VI or III), they failed to react, even though they showed definite reactions to the simple unconjugated salts. It should be emphasized that the chromium content of these conjugates, as determined by tracer technique with labeled Cr51, was in the same range as that of the simple solutions to which the animals were highly reactive (2.1 to 5.0 x 10' M).
DIscussIoN
The techniques described above for inducing sensitization to chromium are reliable and relatively simple. Though Hunziker's method (1) is similar, these modifications have greatly increased the success rate employing dichromate and have, for the first time, allowed consistent achievement of sensitivity in animals using a trivalent salt. The sensitization is long lasting. Animals which were followed for one year retained their reactivity. Frequently the animals developed ulceration at the site of injection of the sensitizing emulsion but this invariably healed in two to three weeks. This occurred with both K2Cr2O7 and CrC13, unlike the typical "chrome ulcers" seen clinically and experimentally which are produced only by hexavalent chromium (7) . Control animals injected only with Freund's complete adjuvant did not develop local ulceration. The mechanism of this reaction at the injection site probably represents local irritation. Successful sensitization occurred in many animals which did not develop ulceration.
Cross-reactivity between hexavalent and trivalent chromium salts has been demonstrated in sensitized subjects (8, 9, 10) . This has been confirmed in guinea pigs by our present experiments. Yet there can be little doubt that K2Cr2O7 is a more effective sensitizer, even when differences in percutaneous absorption are obviated by use of intradermal injections. This has also been the conclusion of Mali et ol. (11) . The reactions to the hexavalent salt were consistently greater in degree. Sensitization was achieved with concentrations ten fold less than CrCI3
Moreover, animals sensitized to K2Cr2O7 showed more cross-reactions, which may be interpreted as an indication of a higher degree of sensitivity.
Similarly, Fregert and Rorsman (12) have shown that the hexavalent chromium salts are more effective elicitors after sensitization has been established.
There are significant variations in the sensitizing and eliciting capacities of the several trivalent salts tested. The more highly dissociated salts produced more reactions than weakly dissociated salts. We have previously postulated that differences in epicutaneous sensitivity were due to differences in diffusion through the epidermis and have confirmed this by diffusion rate measurements in vitro (13) . However, since this route was by-passed in these studies, we are led to the conclusion that the differences in reactivity are also in part inherent in the specific chromium salts. They are probably a function of their degree of dissociation, though Fregert and Rorsman (12) (14) and Cell and Silverstein (15) have masterfully demonstrated that in delayed allergy to simple chemicals there is specificity to the carrier protein as well as the hapten. For example, guinea pigs sensitized to conjugates of pieryl and albumin are more reactive to that conjugate than they are to a conjugate of picryl and globulin. We had hoped this principle would apply to our work with conjugates of chromium and various proteins and could determine what protein binds with chromium in vivo to form the complete antigen. Unfortunately, tIns experiment was unsuccessful. However, since in vitro studies (5) have indicated that the chromium is bound to free amino and free earboxyl groups on the protein molecule, we are currently extending this work, using conjugates of chromium to the synthetic polypeptides poly-1-lysine and poly-1-glutamie acid, which should provide more information on carrier specificity. sUMMAitv Techniques are outlined for the consistent production of delayed hypersensitivity to chromium in guinea pigs. Cross-reactions among various hexavalent and trivalent salts are readily elicited when differences in percutaneous absorption are obviated. A theory of sensitization to chromium is presented which we hope will clarify the controversy over valeney and cxplain the differences observed clinically and experimentally.
